Abstract: The invention relates to a cover for covering a light outlet opening (4) limited by a support rail (1) of a lighting strip system, the support rail (1) being designed to receive a lamp (2) having a light source (3) for producing light, wherein the cover (5) has a holding device (6) for holding at least one optically active element (7) for influencing the light.

Abstract: A fluid dispenser, comprising: an actuator with a rotatable dial; a valve assembly connected to the actuator, the valve assembly being configured so as to cause fluid to be drawn from a reservoir and released from the dispenser during at least part of the time when the dial is rotated from a start position to one of a plurality of dosage positions and back to the start position, the plurality of dosage positions being at different respective angular positions of the dial; the actuator being configured to provide perceptible feedback at each of the plurality of dosage positions.

Abstract: A mounting system (1) for mounting a light fixture comprises two substantially L-shape designed receiving rails (4a, 4b). The receiving rails (4a, 4b) each have a first leg (5a, 5b) which is designed to be fastened to a front side of a suspended wall or an underside of a suspended ceiling (2) on a respective opposite edge of a recess (3) of the wall or ceiling (2).

Abstract: The invention relates to a lighting means support (10) for a strip light luminaire, comprising: at least one spring element (20) for detachably connecting the lighting means support (10) to a strip light rail (1) of a strip light luminaire; wherein the at least one spring element (20) comprises at least one latching element (22) which can be brought into engagement with a correspondingly formed latching element or a correspondingly formed wall section (2) of the strip light rail (1) in order to latch the lighting means support (10) to the strip light rail (1) in such a way that movement of the lighting means support (10) counter to an insertion direction of the lighting means support (10) into the strip light rail (1) is prevented. The invention further relates to a strip light luminaire having at least one lighting means support (10) according to the invention.

Abstract: The present invention relates to a device carrier (10) for a strip-lighting luminaire, comprising: first lines (14) for forming a first power supply circuit; second lines (14) for forming a second power supply circuit; and at least one converter unit (12) for electrically coupling the first to the second power supply circuit, said converter unit being mounted on the device carrier (10). The first lines (14) are arranged on a rear face of the device carrier (10) so that the first lines (14) are concealed by the device carrier (10) in the mounted state of the strip-lighting luminaire. The invention further relates to a strip-lighting luminaire comprising at least one device carrier (10) according to the invention.

Abstract: Herein is reported a method for the production of a polypeptide that is biologically active as n-mer comprising a nucleic acid encoding a fusion polypeptide according to the following formula (Bn-CSo-Is-CSp-FC-CSq-ItCSr-Bm)u, wherein B denotes a polypeptide that is biologically active as n-mer and forms non-defined aggregates/multimers upon expression in the absence of a fused Fc-region, FC denotes a heavy chain Fc-region polypeptide, CS denotes a cleavage site, and I denotes an intervening amino acid sequence, wherein FC does not substantially bind to an Fc-receptor, recovering the fusion polypeptide from the cell or the cultivation medium, optionally cleaving the fusion polypeptide with a protease, and thereby producing a polypeptide that is biologically active as n-mer and forms non-defined aggregates/multimers upon expression in the absence of a fused Fc-region.

Abstract: The invention relates to a lighting-means carrier (5) for a strip-lighting luminaire, comprising: at least one lighting-means circuit board (30) having light-emitting diodes (33) that can be arranged thereon; and at least one heat sink (31) thermally connected to the lighting-means circuit board (30). In a central region, the lighting-means circuit board (30) is rigidly connected to the heat sink (31) in such a way that substantially no relative motion between the lighting-means circuit board (30) and the heat sink (31) is possible. In at least two further regions, the lighting-means circuit board (30) is connected to the heat sink (31) in a floating manner, the lighting-means circuit board (30) therefore being arranged on the heat sink (31) in such a way that the lighting-means circuit board can be moved in relation to the heat sink (31) outside of the central region. The invention further relates to a strip-lighting luminaire having at least one lighting-means carrier (5) according to the invention.

Abstract: The invention relates to a mounting device (1) for mounting holding rails (4a, 4b) for lamp housings to cut-outs (3) of suspended walls or ceilings, comprising a substantially rigid frame (15) and, connected thereto, a first holder (2a) for retaining a first holding rail (4a) and a second holder (2b) for retaining a second holding rail (4b), wherein the holders (2a, 2b) are designed to hold the holding rails (4a, 4b) parallel to and at a defined distance from each other.

Abstract: The present invention relates to Bispecific antibodies against human TWEAK and human IL17 (bispecific TWEAK-IL17 antibodies), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Abstract: Herein is reported a non-covalent complex of a haptenylated antibody that specifically binds to human tau(pS422) and an anti-blood brain barrier receptor/hapten bispecific antibody.

Abstract: Bispecific tetravalent antibodies against IL-17 and TNFa, useful in therapy, e.g. the treatment of rheumatoid arthritis and other autoimmune diseases and/or to reduce pathological inflammatory conditions.

Abstract: A lipid particle comprising an apolipoprotein, a phosphatidylcholine and a lipid, such as a phospholipid, fatty acid or steroid lipid. In one embodiment the lipid particle comprises only one apolipoprotein. In one embodiment the lipid particle is consisting of one apolipoprotein, a phospholipid, a lipid, and a detergent. In one embodiment the lipid is a second phosphatidylcholine, wherein the first phosphatidylcholine and the second phosphatidylcholine differ in one or two fatty acid residues or fatty acid residue derivatives which are esterified to the glycerol backbone of the phosphatidylcholine. In one embodiment the apolipoprotein is selected from an apolipoprotein that has the amino acid sequence selected from SEQ ID NO: 01, 02, 06, 66, and 67, or is a variant thereof that has at least 70% sequence identity with the selected sequence.

Abstract: Herein is reported a shortened tetranectin-apolipoprotein A-I fusion protein and a lipid particle comprising the shortened tetranectin-apolipoprotein A-I fusion protein as well as uses thereof.

Abstract: A method for producing a lipid particle comprising the following: i) providing a first solution comprising denatured apolipoprotein, ii) adding the first solution to a second solution comprising at least two lipids and a detergent but no apolipoprotein, and iii) removing the detergent from the solution obtained in ii) and thereby producing a lipid particle.

Abstract: Herein is reported a method for the production of a polypeptide that is biologically active as n-mer comprising a nucleic acid encoding a fusion polypeptide according to the following formula (Bn—CSo—Is—CSp—FC—CSq—It—CSr—Bm)u, wherein B denotes a polypeptide that is biologically active as n-mer and forms non-defined aggregates/multimers upon expression in the absence of a fused Fc-region, FC denotes a heavy chain Fc-region polypeptide, CS denotes a cleavage site, and I denotes an intervening amino acid sequence, wherein FC does not substantially bind to an Fc-receptor, recovering the fusion polypeptide from the cell or the cultivation medium, optionally cleaving the fusion polypeptide with a protease, and thereby producing a polypeptide that is biologically active as n-mer and forms non-defined aggregates/multimers upon expression in the absence of a fused Fc-region.

Abstract: The present invention relates to Bispecific antibodies against human TWEAK and human IL17 (bispecific TWEAK-IL17 antibodies), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof

Abstract: Herein is reported a shortened tetranectin-apolipoprotein A-I fusion protein and a lipid particle comprising the shortened tetranectin-apolipoprotein A-I fusion protein as well as uses thereof.

Abstract: Herein is reported a shortened tetranectin-apolipoprotein A-I fusion protein and a lipid particle comprising the shortened tetranectin-apolipoprotein A-I fusion protein as well as uses thereof.

Abstract: Herein is reported a shortened tetranectin-apolipoprotein A-I fusion protein and a lipid particle comprising the shortened tetranectin-apolipoprotein A-I fusion protein as well as uses thereof.

Abstract: A method is disclosed for creating an IP right valuation index for an IP portfolio related to an IP right comprising: capturing a quality indicator signal relating to quality indicator data of the IP right; generating a technology field signal relating to a technology field of the IP right; measuring individual IP technology relevance comprising a ratio of the generated technology field signal and the captured quality indicator signal; capturing a total number signal relating to a total number of IP rights in the technology field; determining an IP portfolio signal relating to the number of IP rights within the captured total number signal having ownership of the IP right; measuring IP portfolio strength comprising a ratio of the determined IP portfolio signal and the captured total number signal; and creating an IP right valuation index comprising a product of the individual IP technology relevance and the IP portfolio strength.